A detailed history of Pure Financial Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pure Financial Advisors, LLC holds 5,270 shares of BMY stock, worth $303,973. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,270
Previous 5,137 2.59%
Holding current value
$303,973
Previous $213,000 27.7%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$39.66 - $51.75 $5,274 - $6,882
133 Added 2.59%
5,270 $272,000
Q2 2024

Jul 18, 2024

SELL
$40.25 - $52.99 $7,084 - $9,326
-176 Reduced 3.31%
5,137 $213,000
Q1 2024

Apr 16, 2024

SELL
$47.98 - $54.4 $82,333 - $93,350
-1,716 Reduced 24.41%
5,313 $288,000
Q4 2023

Jan 08, 2024

BUY
$48.48 - $57.85 $62,975 - $75,147
1,299 Added 22.67%
7,029 $360,000
Q3 2023

Oct 10, 2023

SELL
$57.89 - $64.73 $75,778 - $84,731
-1,309 Reduced 18.6%
5,730 $332,000
Q2 2023

Jul 10, 2023

SELL
$63.71 - $70.74 $41,921 - $46,546
-658 Reduced 8.55%
7,039 $450,000
Q1 2023

Apr 11, 2023

BUY
$65.71 - $74.53 $59,336 - $67,300
903 Added 13.29%
7,697 $533,000
Q4 2022

Jan 09, 2023

SELL
$68.48 - $81.09 $24,515 - $29,030
-358 Reduced 5.01%
6,794 $0
Q3 2022

Oct 06, 2022

BUY
$0.13 - $76.84 $331 - $195,711
2,547 Added 55.31%
7,152 $508,000
Q2 2022

Jul 08, 2022

BUY
$72.62 - $79.98 $6,971 - $7,678
96 Added 2.13%
4,605 $355,000
Q1 2022

Apr 12, 2022

BUY
$61.48 - $73.72 $47,155 - $56,543
767 Added 20.5%
4,509 $329,000
Q4 2021

Jan 12, 2022

BUY
$53.63 - $62.52 $9,867 - $11,503
184 Added 5.17%
3,742 $233,000
Q3 2021

Oct 07, 2021

BUY
$59.17 - $69.31 $6,627 - $7,762
112 Added 3.25%
3,558 $211,000
Q2 2021

Jul 09, 2021

SELL
$61.91 - $67.42 $4,333 - $4,719
-70 Reduced 1.99%
3,446 $230,000
Q1 2021

Apr 09, 2021

BUY
$59.34 - $66.74 $1,720 - $1,935
29 Added 0.83%
3,516 $222,000
Q2 2020

Jul 08, 2020

BUY
$54.82 - $64.09 $191,157 - $223,481
3,487 New
3,487 $205,000
Q1 2020

Apr 07, 2020

SELL
$46.4 - $67.43 $175,624 - $255,222
-3,785 Closed
0 $0
Q4 2019

Jan 09, 2020

BUY
$49.21 - $64.19 $186,259 - $242,959
3,785 New
3,785 $243,000
Q4 2018

Jan 11, 2019

SELL
$48.76 - $63.23 $157,933 - $204,801
-3,239 Closed
0 $0
Q3 2018

Oct 04, 2018

BUY
$55.19 - $62.25 $178,760 - $201,627
3,239 New
3,239 $201,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pure Financial Advisors, LLC Portfolio

Follow Pure Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pure Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pure Financial Advisors, LLC with notifications on news.